HDAC9 and colorectal cancer: It has been shown that in colorectal cancer, collagen type XI alpha 1 (COL11A1) [60] with histone deacetylase 9 (HDAC9) [61] affects the PI3K/AKT and TP53 signaling pathways, leading to uncontrolled tumor invasion.